As per the USFDA, a VAI inspection classification indicates that
although investigators found and documented objectionable conditions
during the inspection, FDA will not take or recommend regulatory or
enforcement action because the objectionable conditions do not meet
the threshold for action at this time.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-vai-classification-from-usfda-for-hyderabad-unit/articleshow/75267154.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment